Six-month surveillance of <i>Candida parapsilosis</i> in Tyrol, Austria: high-risk ST11 lineage and early, heterogeneous fluconazole resistance. [PDF]
Steixner S +4 more
europepmc +1 more source
Therapeutic drug monitoring of voriconazole : validation of a novel ARK™ immunoassay and comparison with ultra-high performance liquid chromatography [PDF]
Cattoir, Lien +5 more
core +1 more source
Antifungal susceptibility profiles of candidemia isolates on the east coast of Peninsular Malaysia and reliability of Etest compared to Sensititre YeastOne. [PDF]
Abdullah SNS, Tzar MN, Othman SN.
europepmc +1 more source
Candidemia in Southern Poland (2017-2022): Multicenter Analysis of Species Distribution and Antifungal Susceptibility. [PDF]
Namysł M +8 more
europepmc +1 more source
Antifungal Susceptibility of Clinical <i>Meyerozyma guillermondii</i> Isolates Obtained Between 1994 and 2014: Original Research and Comparison with Published Data. [PDF]
Górzyńska A +5 more
europepmc +1 more source
Rezafungin for the treatment of invasive candidiasis secondary to esophagogastric anastomotic leak: clinical success in a complex situation. [PDF]
Estévez A +4 more
europepmc +1 more source
<i>Lomentospora prolificans</i> infective endocarditis and cerebral mycotic aneurysm. [PDF]
Hand R +5 more
europepmc +1 more source
Susceptibility to echinocandins of spp. strains isolated in Italy assessed by European Committee for Antimicrobial Susceptibility Testing and Clinical Laboratory Standards Institute broth microdilution methods [PDF]
core +1 more source
Beyond <i>Candida</i>: Epidemiological Insights into Rare Yeast Fungaemia in Greece from a 15-Year Hospital-Based Study and Literature Review. [PDF]
Siopi M +5 more
europepmc +1 more source
Deciphering the multidrug resistance paradigm in <i>Candida auris</i>. [PDF]
Santana DJ +3 more
europepmc +1 more source

